Structure

Physi-Chem Properties

Molecular Weight:  552.18
Volume:  519.844
LogP:  0.65
LogD:  0.778
LogS:  -2.717
# Rotatable Bonds:  11
TPSA:  204.83
# H-Bond Aceptor:  13
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.173
Synthetic Accessibility Score:  4.412
Fsp3:  0.5
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.35
MDCK Permeability:  1.543759208288975e-05
Pgp-inhibitor:  0.006
Pgp-substrate:  0.179
Human Intestinal Absorption (HIA):  0.981
20% Bioavailability (F20%):  0.964
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.166
Plasma Protein Binding (PPB):  88.17931365966797%
Volume Distribution (VD):  0.358
Pgp-substrate:  22.430055618286133%

ADMET: Metabolism

CYP1A2-inhibitor:  0.018
CYP1A2-substrate:  0.027
CYP2C19-inhibitor:  0.025
CYP2C19-substrate:  0.057
CYP2C9-inhibitor:  0.009
CYP2C9-substrate:  0.415
CYP2D6-inhibitor:  0.018
CYP2D6-substrate:  0.128
CYP3A4-inhibitor:  0.166
CYP3A4-substrate:  0.079

ADMET: Excretion

Clearance (CL):  1.393
Half-life (T1/2):  0.823

ADMET: Toxicity

hERG Blockers:  0.279
Human Hepatotoxicity (H-HT):  0.045
Drug-inuced Liver Injury (DILI):  0.164
AMES Toxicity:  0.156
Rat Oral Acute Toxicity:  0.057
Maximum Recommended Daily Dose:  0.001
Skin Sensitization:  0.699
Carcinogencity:  0.34
Eye Corrosion:  0.003
Eye Irritation:  0.039
Respiratory Toxicity:  0.009

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC478250

Natural Product ID:  NPC478250
Common Name*:   2-(4-hydroxyphenyl)ethyl[5-O-(4-hydroxybenzoyl)]-O--D-apiofuranosyl-(1?2)--D-glucopyranoside
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  MWVDTRFZEALNIG-ZFAXPZJCSA-N
Standard InCHI:  InChI=1S/C26H32O13/c27-11-18-19(30)20(31)21(24(38-18)35-10-9-14-1-5-16(28)6-2-14)39-25-22(32)26(34,13-37-25)12-36-23(33)15-3-7-17(29)8-4-15/h1-8,18-22,24-25,27-32,34H,9-13H2/t18?,19?,20-,21+,22-,24-,25+,26+/m1/s1
SMILES:  [H]C1=CC(C(=O)OC[C@]2(O)CO[C@@H](O[C@@H]3[C@H](OCCC4=CC=C(O)C=C4)OC(CO)C(O)[C@H]3O)[C@H]2O)=CC=C1O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota stem bark Medicinal Plant Garden, College of Pharmacy, Ewha Womans University 2013-DEC PMID[28787158]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. PMID[9599262]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC478250 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9556 High Similarity NPC471345
0.9191 High Similarity NPC114116
0.9185 High Similarity NPC478255
0.9091 High Similarity NPC473867
0.9091 High Similarity NPC291153
0.9085 High Similarity NPC473281
0.9085 High Similarity NPC77922
0.906 High Similarity NPC226759
0.8973 High Similarity NPC182350
0.8963 High Similarity NPC225307
0.8912 High Similarity NPC289021
0.8912 High Similarity NPC158546
0.8912 High Similarity NPC140151
0.8904 High Similarity NPC478234
0.8904 High Similarity NPC478236
0.8889 High Similarity NPC288416
0.8873 High Similarity NPC80098
0.8851 High Similarity NPC478235
0.8819 High Similarity NPC471028
0.8811 High Similarity NPC469623
0.8811 High Similarity NPC65833
0.8811 High Similarity NPC148080
0.8808 High Similarity NPC187205
0.8792 High Similarity NPC229354
0.8784 High Similarity NPC474620
0.8777 High Similarity NPC164172
0.8776 High Similarity NPC75945
0.8776 High Similarity NPC92117
0.8768 High Similarity NPC225384
0.8768 High Similarity NPC138777
0.8768 High Similarity NPC235294
0.8768 High Similarity NPC46137
0.8768 High Similarity NPC246869
0.8767 High Similarity NPC473149
0.8759 High Similarity NPC475528
0.8742 High Similarity NPC265480
0.8742 High Similarity NPC149368
0.8732 High Similarity NPC171134
0.8732 High Similarity NPC321638
0.8732 High Similarity NPC321184
0.8732 High Similarity NPC328273
0.8725 High Similarity NPC194705
0.8716 High Similarity NPC116292
0.8716 High Similarity NPC87630
0.8716 High Similarity NPC179128
0.8716 High Similarity NPC35097
0.8716 High Similarity NPC267469
0.8714 High Similarity NPC169398
0.8707 High Similarity NPC120728
0.8707 High Similarity NPC120621
0.8707 High Similarity NPC248257
0.8705 High Similarity NPC471095
0.8705 High Similarity NPC471066
0.8699 High Similarity NPC143246
0.8699 High Similarity NPC474268
0.8699 High Similarity NPC208293
0.8699 High Similarity NPC475539
0.8699 High Similarity NPC119773
0.869 High Similarity NPC296659
0.869 High Similarity NPC202391
0.8681 High Similarity NPC245219
0.8681 High Similarity NPC31081
0.8675 High Similarity NPC10205
0.8667 High Similarity NPC257847
0.8667 High Similarity NPC157898
0.8662 High Similarity NPC302583
0.8662 High Similarity NPC310252
0.8662 High Similarity NPC100558
0.8662 High Similarity NPC84789
0.8654 High Similarity NPC469419
0.8654 High Similarity NPC469396
0.8654 High Similarity NPC469459
0.8654 High Similarity NPC149002
0.8654 High Similarity NPC469458
0.8654 High Similarity NPC88176
0.8645 High Similarity NPC109990
0.8643 High Similarity NPC28637
0.8636 High Similarity NPC477627
0.8633 High Similarity NPC281798
0.8618 High Similarity NPC471405
0.8613 High Similarity NPC106677
0.8613 High Similarity NPC35288
0.8613 High Similarity NPC148026
0.8613 High Similarity NPC173150
0.8613 High Similarity NPC45224
0.8613 High Similarity NPC471881
0.8613 High Similarity NPC156692
0.8613 High Similarity NPC471882
0.8611 High Similarity NPC79908
0.8609 High Similarity NPC327032
0.8609 High Similarity NPC191046
0.8609 High Similarity NPC194095
0.8603 High Similarity NPC83218
0.8603 High Similarity NPC126991
0.86 High Similarity NPC134905
0.86 High Similarity NPC36130
0.8591 High Similarity NPC162569
0.8591 High Similarity NPC35160
0.8591 High Similarity NPC240592
0.8591 High Similarity NPC117346
0.8581 High Similarity NPC145847
0.8571 High Similarity NPC200708
0.8562 High Similarity NPC4747
0.8562 High Similarity NPC472860
0.8562 High Similarity NPC43638
0.8562 High Similarity NPC63304
0.8562 High Similarity NPC194938
0.8562 High Similarity NPC122809
0.8562 High Similarity NPC104275
0.8561 High Similarity NPC17968
0.8561 High Similarity NPC469705
0.8561 High Similarity NPC470122
0.8551 High Similarity NPC301857
0.8543 High Similarity NPC16024
0.8543 High Similarity NPC61152
0.8543 High Similarity NPC88484
0.8543 High Similarity NPC137813
0.8543 High Similarity NPC205037
0.8543 High Similarity NPC3746
0.8543 High Similarity NPC259767
0.8543 High Similarity NPC44260
0.854 High Similarity NPC252114
0.854 High Similarity NPC471157
0.854 High Similarity NPC114096
0.854 High Similarity NPC61181
0.8531 High Similarity NPC469696
0.8531 High Similarity NPC101686
0.8531 High Similarity NPC469364
0.8531 High Similarity NPC65262
0.8523 High Similarity NPC111785
0.8523 High Similarity NPC161955
0.8523 High Similarity NPC96599
0.8521 High Similarity NPC123988
0.8521 High Similarity NPC263829
0.8519 High Similarity NPC52097
0.8516 High Similarity NPC293568
0.8516 High Similarity NPC117943
0.8503 High Similarity NPC108455
0.8497 Intermediate Similarity NPC127406
0.8493 Intermediate Similarity NPC105005
0.8493 Intermediate Similarity NPC242756
0.8493 Intermediate Similarity NPC40305
0.8489 Intermediate Similarity NPC469549
0.8478 Intermediate Similarity NPC103533
0.8472 Intermediate Similarity NPC220936
0.8472 Intermediate Similarity NPC31745
0.8471 Intermediate Similarity NPC72016
0.8467 Intermediate Similarity NPC88886
0.8467 Intermediate Similarity NPC123704
0.8467 Intermediate Similarity NPC104172
0.8462 Intermediate Similarity NPC294470
0.8462 Intermediate Similarity NPC472132
0.8456 Intermediate Similarity NPC470907
0.8456 Intermediate Similarity NPC178449
0.8456 Intermediate Similarity NPC232454
0.8456 Intermediate Similarity NPC140722
0.8456 Intermediate Similarity NPC92054
0.8456 Intermediate Similarity NPC4958
0.8452 Intermediate Similarity NPC239966
0.8452 Intermediate Similarity NPC203020
0.8452 Intermediate Similarity NPC130489
0.8452 Intermediate Similarity NPC208676
0.8451 Intermediate Similarity NPC34293
0.8451 Intermediate Similarity NPC886
0.8451 Intermediate Similarity NPC287597
0.8446 Intermediate Similarity NPC474044
0.8446 Intermediate Similarity NPC212808
0.8446 Intermediate Similarity NPC473147
0.8444 Intermediate Similarity NPC11724
0.8442 Intermediate Similarity NPC257309
0.8442 Intermediate Similarity NPC49173
0.8442 Intermediate Similarity NPC133984
0.844 Intermediate Similarity NPC302844
0.8438 Intermediate Similarity NPC477617
0.8438 Intermediate Similarity NPC148185
0.8435 Intermediate Similarity NPC121573
0.8435 Intermediate Similarity NPC229036
0.8435 Intermediate Similarity NPC190587
0.8435 Intermediate Similarity NPC22176
0.8435 Intermediate Similarity NPC300894
0.8435 Intermediate Similarity NPC141455
0.8435 Intermediate Similarity NPC296954
0.8435 Intermediate Similarity NPC196063
0.8435 Intermediate Similarity NPC226738
0.8431 Intermediate Similarity NPC172920
0.8431 Intermediate Similarity NPC156624
0.8431 Intermediate Similarity NPC203757
0.8431 Intermediate Similarity NPC99233
0.8428 Intermediate Similarity NPC21956
0.8421 Intermediate Similarity NPC44730
0.8421 Intermediate Similarity NPC259182
0.8421 Intermediate Similarity NPC121001
0.8417 Intermediate Similarity NPC158673
0.8403 Intermediate Similarity NPC260425
0.8403 Intermediate Similarity NPC78363
0.84 Intermediate Similarity NPC22137
0.84 Intermediate Similarity NPC478242
0.8397 Intermediate Similarity NPC477628
0.8397 Intermediate Similarity NPC210961
0.8397 Intermediate Similarity NPC195685

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC478250 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8345 Intermediate Similarity NPD7266 Discontinued
0.8323 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD7685 Pre-registration
0.8121 Intermediate Similarity NPD6190 Approved
0.8054 Intermediate Similarity NPD4628 Phase 3
0.8042 Intermediate Similarity NPD3764 Approved
0.8025 Intermediate Similarity NPD3818 Discontinued
0.8015 Intermediate Similarity NPD9545 Approved
0.7935 Intermediate Similarity NPD4380 Phase 2
0.7895 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7866 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7866 Intermediate Similarity NPD7054 Approved
0.7862 Intermediate Similarity NPD7075 Discontinued
0.7831 Intermediate Similarity NPD6559 Discontinued
0.7818 Intermediate Similarity NPD7472 Approved
0.7818 Intermediate Similarity NPD7074 Phase 3
0.7799 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD8455 Phase 2
0.7784 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7725 Intermediate Similarity NPD7251 Discontinued
0.7679 Intermediate Similarity NPD7808 Phase 3
0.7673 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD6797 Phase 2
0.7647 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7635 Intermediate Similarity NPD230 Phase 1
0.7632 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD6801 Discontinued
0.7566 Intermediate Similarity NPD1549 Phase 2
0.7548 Intermediate Similarity NPD6799 Approved
0.7532 Intermediate Similarity NPD7458 Discontinued
0.7529 Intermediate Similarity NPD8313 Approved
0.7529 Intermediate Similarity NPD8312 Approved
0.7516 Intermediate Similarity NPD5403 Approved
0.75 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7228 Approved
0.745 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD7411 Suspended
0.7432 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD37 Approved
0.7391 Intermediate Similarity NPD1934 Approved
0.7389 Intermediate Similarity NPD5401 Approved
0.7383 Intermediate Similarity NPD6233 Phase 2
0.7378 Intermediate Similarity NPD6234 Discontinued
0.7368 Intermediate Similarity NPD1510 Phase 2
0.7368 Intermediate Similarity NPD7033 Discontinued
0.7365 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD4965 Approved
0.7362 Intermediate Similarity NPD4967 Phase 2
0.7362 Intermediate Similarity NPD4966 Approved
0.7358 Intermediate Similarity NPD1653 Approved
0.7353 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD7819 Suspended
0.7346 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD3817 Phase 2
0.7301 Intermediate Similarity NPD5402 Approved
0.7292 Intermediate Similarity NPD1091 Approved
0.7289 Intermediate Similarity NPD7199 Phase 2
0.7279 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD6599 Discontinued
0.7262 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD6166 Phase 2
0.7256 Intermediate Similarity NPD3882 Suspended
0.7244 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD3750 Approved
0.7235 Intermediate Similarity NPD5844 Phase 1
0.7219 Intermediate Similarity NPD1240 Approved
0.7213 Intermediate Similarity NPD7435 Discontinued
0.7212 Intermediate Similarity NPD3749 Approved
0.7208 Intermediate Similarity NPD2935 Discontinued
0.72 Intermediate Similarity NPD6798 Discontinued
0.72 Intermediate Similarity NPD8150 Discontinued
0.72 Intermediate Similarity NPD8434 Phase 2
0.7195 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD7097 Phase 1
0.7181 Intermediate Similarity NPD6832 Phase 2
0.7176 Intermediate Similarity NPD7799 Discontinued
0.7174 Intermediate Similarity NPD8320 Phase 1
0.7174 Intermediate Similarity NPD8319 Approved
0.7171 Intermediate Similarity NPD6355 Discontinued
0.7171 Intermediate Similarity NPD1933 Approved
0.717 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD8389 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD7440 Discontinued
0.7151 Intermediate Similarity NPD7585 Approved
0.7151 Intermediate Similarity NPD6535 Approved
0.7151 Intermediate Similarity NPD6534 Approved
0.7135 Intermediate Similarity NPD7999 Approved
0.7134 Intermediate Similarity NPD2801 Approved
0.7134 Intermediate Similarity NPD1465 Phase 2
0.7127 Intermediate Similarity NPD7700 Phase 2
0.7127 Intermediate Similarity NPD7699 Phase 2
0.7124 Intermediate Similarity NPD1607 Approved
0.7122 Intermediate Similarity NPD969 Suspended
0.7119 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD9493 Approved
0.711 Intermediate Similarity NPD7240 Approved
0.7107 Intermediate Similarity NPD1511 Approved
0.7101 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD3455 Phase 2
0.7097 Intermediate Similarity NPD7583 Approved
0.7097 Intermediate Similarity NPD2796 Approved
0.7097 Intermediate Similarity NPD1551 Phase 2
0.7095 Intermediate Similarity NPD1203 Approved
0.7089 Intermediate Similarity NPD2354 Approved
0.7089 Intermediate Similarity NPD3887 Approved
0.7076 Intermediate Similarity NPD3751 Discontinued
0.7059 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD6777 Approved
0.7049 Intermediate Similarity NPD6776 Approved
0.7049 Intermediate Similarity NPD6778 Approved
0.7049 Intermediate Similarity NPD6779 Approved
0.7049 Intermediate Similarity NPD6780 Approved
0.7049 Intermediate Similarity NPD6781 Approved
0.7049 Intermediate Similarity NPD6782 Approved
0.7048 Intermediate Similarity NPD7768 Phase 2
0.7044 Intermediate Similarity NPD5058 Phase 3
0.7041 Intermediate Similarity NPD6232 Discontinued
0.7039 Intermediate Similarity NPD4062 Phase 3
0.7034 Intermediate Similarity NPD5125 Phase 3
0.7034 Intermediate Similarity NPD5126 Approved
0.7019 Intermediate Similarity NPD1512 Approved
0.7018 Intermediate Similarity NPD7473 Discontinued
0.7016 Intermediate Similarity NPD7930 Approved
0.7012 Intermediate Similarity NPD6385 Approved
0.7012 Intermediate Similarity NPD6386 Approved
0.7007 Intermediate Similarity NPD9269 Phase 2
0.7007 Intermediate Similarity NPD1481 Phase 2
0.7006 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD7584 Approved
0.6984 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6984 Remote Similarity NPD7874 Approved
0.6957 Remote Similarity NPD2533 Approved
0.6957 Remote Similarity NPD2532 Approved
0.6957 Remote Similarity NPD2534 Approved
0.6948 Remote Similarity NPD4340 Discontinued
0.6947 Remote Similarity NPD7783 Phase 2
0.6947 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6941 Remote Similarity NPD3787 Discontinued
0.6939 Remote Similarity NPD1535 Discovery
0.6936 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6935 Remote Similarity NPD7697 Approved
0.6935 Remote Similarity NPD7696 Phase 3
0.6935 Remote Similarity NPD7698 Approved
0.6931 Remote Similarity NPD8151 Discontinued
0.6923 Remote Similarity NPD4308 Phase 3
0.6923 Remote Similarity NPD5494 Approved
0.6923 Remote Similarity NPD3748 Approved
0.6918 Remote Similarity NPD8166 Discontinued
0.6914 Remote Similarity NPD6273 Approved
0.6913 Remote Similarity NPD3225 Approved
0.6906 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6906 Remote Similarity NPD6213 Phase 3
0.6906 Remote Similarity NPD6212 Phase 3
0.6898 Remote Similarity NPD7870 Phase 2
0.6898 Remote Similarity NPD7871 Phase 2
0.6897 Remote Similarity NPD1894 Discontinued
0.6892 Remote Similarity NPD1608 Approved
0.6892 Remote Similarity NPD3972 Approved
0.689 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6887 Remote Similarity NPD9494 Approved
0.6883 Remote Similarity NPD943 Approved
0.6882 Remote Similarity NPD6823 Phase 2
0.6878 Remote Similarity NPD7701 Phase 2
0.6867 Remote Similarity NPD2797 Approved
0.6863 Remote Similarity NPD3268 Approved
0.6863 Remote Similarity NPD2313 Discontinued
0.6855 Remote Similarity NPD1652 Phase 2
0.6849 Remote Similarity NPD9268 Approved
0.6835 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6835 Remote Similarity NPD2344 Approved
0.6835 Remote Similarity NPD2353 Approved
0.6832 Remote Similarity NPD7236 Approved
0.6824 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6821 Remote Similarity NPD2798 Approved
0.6815 Remote Similarity NPD2799 Discontinued
0.6815 Remote Similarity NPD1238 Approved
0.6813 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6809 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6807 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6798 Remote Similarity NPD8407 Phase 2
0.6797 Remote Similarity NPD3027 Phase 3
0.6797 Remote Similarity NPD7095 Approved
0.6795 Remote Similarity NPD6653 Approved
0.6793 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6788 Remote Similarity NPD3226 Approved
0.6786 Remote Similarity NPD5353 Approved
0.6784 Remote Similarity NPD8127 Discontinued
0.6784 Remote Similarity NPD6959 Discontinued
0.6779 Remote Similarity NPD9717 Approved
0.6774 Remote Similarity NPD1613 Approved
0.6774 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6772 Remote Similarity NPD5404 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data